Tenderwize
Back to tender search

Open-house discount agreement for Levothyroxin-Natrium

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Mar 03, 2028 · 563 days left·Open·Supplies·Framework
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Levothyroxin-Natrium, ATC H03AA01

58/100

Opportunity Score

Needs reviewMedium complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

58 / 100

Complexity

54 / 100

Risk factors

The buyer explicitly states that this is an open-house model and not a normal open procedure; standard procurement assu...

Contract documents must be submitted through the communication area in the DTVP portal, not through the offer area; mis...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Apr 2028
  • Non-exclusive supply/discount agreement for Levothyroxin-Natrium, ATC H03AA01.
  • Open-house accession model with identical, pre-set contract terms for qualifying pharmaceutical companies.
Show full summary

This is an open-house supply arrangement for pharmaceutical discount agreements on Levothyroxin-Natrium (ATC H03AA01) with AOK Bayern. It is not a competitive open procedure in the usual sense: the buyer states that all interested pharmaceutical companies meeting the stated suitability requirement can join on identical, non-negotiable terms. The contract term starts earliest on 2026-05-01 and ends on 2028-04-30, with a final contract entry deadline of 2028-03-03 11:00. No estimated contract value is provided.

Risks

The buyer explicitly states that this is an open-house model and not a normal open procedure; standard procurement assu...

Contract documents must be submitted through the communication area in the DTVP portal, not through the offer area; mis...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Contract and annex 'Festlegung der vertragsgegenständlichen Arzneimittel' must be completed and signed.

Eligibility

  • Only pharmaceutical companies are eligible as potential contract partners.

Administrative

  • Signed declaration of reliability must be submitted.

Award Criteria

Lot 1

No lot-specific award criteria are stated; this appears to be an open-house accession model rather than a scored award process.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open-house discount agreement for Levothyroxin-Natrium

Single lot covering non-exclusive open-house discount agreements for the pharmaceutical product Levothyroxin-Natrium (ATC H03AA01). The buyer indicates that contracts are identical, non-individually negotiable, and open to all interested pharmaceutical companies meeting the stated suitability requirement. Performance is in Germany, Bayern (DE212).

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Apr 2026 - Apr 2028

Category

Pharmaceutical products

Award Criteria

No lot-specific award criteria are stated; this appears to be an open-house accession model rather than a scored award process.

Deadline

Deadline Mar 03, 2028

Procurement Details

Publication date
15 Mar 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
180221-2026

Documents (2)

Similar tenders